NEW YORK (GenomeWeb News) – Researchers at the University of Miami School of Medicine plan to use a five-year, $2.5 million grant from the National Institute of Dental and Craniofacial Research to discover DNA variants that may function as biomarkers for susceptibility and therapeutic response for patients who suffer from persistent pain, the university said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.